Schering-Plough Corporation http://www.alacrastore.com/company-snapshot/Schering_Plough_Corporation-1014876 Wednesday, July 23, 2008 6:20:57 PM 1014876 Schering-Plough Corporation en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/ccbn/B1906430ccbn/B1906430norm...SEAS study looked at a possible new use for VYTORIN in patients with Aortic Stenosis that is hard or poorly functioning heart valves. ... 7/23/2008 12:07:27 PMSchering-Plough106.0000EditedQ2 2008 Schering-Plough Earnings Conference Call SummarySGP4:45pm ETBriefB1906430Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/moodys/CMT_0000446809moodys/CMT_0000446809htmlGlobal Credit Research Issuer Comment ## JUL #### Issuer Comment: Schering-Plough Corporation Moody's comments on Schering-Plough's rating post-SEAS Moody's Investors Service commented that the ratings of Schering-Plough Corporation...7/23/2008 12:43:14 AMhtmlSchering-Plough CorporationSchering-Plough Corporation663000150.0000NewsIssuer CommentCMT_0000446809Credit & Investment ResearchMoody's Global Credit Researchhttp://www.alacrastore.com/storecontent/newstex/PRN-0004-26822848newstex/PRN-0004-26822848xml London, Jul. ##, #### (PR Newswire UK Disclose delivered by Newstex) -- Schering-Plough Reports Financial Results for Second Quarter of #### Broad-Based Performance and Robust Phase III Pipeline Validate...0700000007005000010000000102100004000000040160000401601304016018040160480401600104016005040160030400200004002006040100000401000107001000070010050700300007003001070140000701401207014006070140097/22/2008 3:16:47 AM180000001801500018004000180220001801600018020000180080001802300019000000190010001900200019002007190020091900201319002004PR Newswire UK DisclosePRN-0004-26822848SCHERING PLOUGH CORPSCHERING-PLOUGH CORPORATION 6.00% MANDATORY CONVERTIBLEFRED HASSANSGPSGP PRBNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T1906430ccbn/T1906430norm...Good afternoon. My name is Ellie and I will be your conference operator today. At this time, I would like to welcome everyone to the Schering-Plough #### second quarter earnings conference call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. (OPERATOR INSTRUCTIONS). Thank you. I would now like to turn the conference over to Ms. Janet Barth, Vice President of Investor Relations. Ms. Barth, you may begin your conference. ... 7/21/2008 6:05:00 PMSchering-Plough106.0000FinalQ2 2008 Schering-Plough Earnings Conference Call TranscriptSGP4:45pm ETTranscriptT1906430Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/newstex/PRN-0005-26813927newstex/PRN-0005-26813927xml KENILWORTH, N.J., Jul. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Schering-Plough Corporation (NYSE: SGP) today reported financial results for the second quarter of ####."We are very pleased to see another quarter of strong...0700000007005000010000000102100004000000040160000401601304016018040160480401600104016005040160030400200004002006040100000401000107001000070010050700300007003001070140000701401207014006070140097/21/2008 5:17:51 PM180000001801500018004000180220001801600018020000180080001802300019000000190010001900200019002007190020091900201319002004PR Newswire USPRN-0005-26813927SCHERING PLOUGH CORPSCHERING-PLOUGH CORPORATION 6.00% MANDATORY CONVERTIBLEFRED HASSANSGPSGP PRBNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-26799836newstex/PRN-0005-26799836xml KENILWORTH, N.J., Jul. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Schering-Plough Corporation (NYSE: SGP) has rescheduled the time of its conference call and webcast to review the sales and earnings results for the ####...040000000401600004016018040160480401600104002000040020067/21/2008 2:21:53 PM180000001800400018008000PR Newswire USPRN-0005-26799836SCHERING PLOUGH CORPSCHERING-PLOUGH CORPORATION 6.00% MANDATORY CONVERTIBLESGPSGP PRBNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0004-26799891newstex/PRN-0004-26799891xml London, Jul. ##, #### (PR Newswire UK Disclose delivered by Newstex) -- Schering-Plough Reschedules Time of Conference Call, Webcast for #### Second Quarter Earnings to Later Today KENILWORTH, N.J., July ##...040000000401600004016018040160480401600104002000040020067/21/2008 2:21:52 PM180000001800400018008000PR Newswire UK DisclosePRN-0004-26799891SCHERING PLOUGH CORPSCHERING-PLOUGH CORPORATION 6.00% MANDATORY CONVERTIBLESGPSGP PRBNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0001-26803291newstex/PRN-0001-26803291xml EDMONTON, Jul. ##, #### (Canada NewsWire Group delivered by Newstex) -- /CNW/ -- EPCOR Power L.P. (TSX: EP.UN) (the Partnership), announced today that it has amended and extended the power purchase arrangement and steam purchase agreement...0400000004016000040160137/21/2008 10:00:15 AM180000001801500018022000Canada NewsWire GroupPRN-0001-26803291EPCOR POWER L.P.SCHERING PLOUGH CORPSCHERING-PLOUGH CORPORATION 6.00% MANDATORY CONVERTIBLEEP.UNSGPSGP PRBNewsNewstexhttp://www.alacrastore.com/storecontent/fitch/393346_report_framefitch/393346_report_framepdfFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.AmerisourceBergen CorporationBoston Scientific CorporationCardinal Health, Inc.Community Health Systems, Inc.DaVita, Inc.Express Scripts, Inc.HCA Inc.Health Management Associates, Inc.Lifepoint Hospitals, Inc.McKesson CorporationMedco Health Solutions, IncOwens & Minor, Inc.Schering-Plough CorporationTenet Healthcare CorporationThermo Fisher Scientific IncUniversal Health Services, Inc.Watson Pharmaceuticals, Inc.101000013280089368800893698008952680090087800902068009062880091113800911668009159180092087807104108160965581683472816834998184136581841380829531257/16/2008 6:31:00 PM010300000103170001031702010317030104000003020400275Special ReportABCBSXCAHCYHDVAESRXHMALPNTMCKMHSOMISGPTHCTMOUHSWPI393346_report_frameCredit & Investment ResearchFitchResearchhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-26383415newstex/PRN-0005-26383415xml KENILWORTH, N.J., Jul. #, #### (PRNewswire-FirstCall delivered by Newstex) -- Schering-Plough Corporation (NYSE: SGP) today announced the successful closing of its previously announced transaction with Virbac, S.A. to divest animal...0400000004002000040020060401600004016005070000000700300007003006070030017/2/2008 3:15:21 AM1800000018016000180200001900000019003000PR Newswire USPRN-0005-26383415SCHERING PLOUGH CORPSCHERING-PLOUGH CORPORATION 6.00% MANDATORY CONVERTIBLESGPSGP PRBNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-26284359newstex/PRN-0005-26284359xml WHITEHOUSE STATION, N.J., Jun. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Schering-Plough Corp. (NYSE: SGP) and Merck & Co., Inc. (NYSE: MRK) announce the withdrawal of the New Drug Application (NDA) for the loratadine/montelukast...04000000040160000401601304002000040020066/27/2008 9:18:15 AM18000000180150001802200018016000PR Newswire USPRN-0005-26284359MERCK & CO INCSCHERING PLOUGH CORPSCHERING-PLOUGH CORPORATION 6.00% MANDATORY CONVERTIBLEMRKSGPSGP PRBNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-26040664newstex/PRN-0005-26040664xml KENILWORTH, N.J., Jun. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Schering-Plough Corporation (NYSE: SGP) is scheduled to announce its sales and earnings results for the #### second quarter on Monday, July ##, ####.At #...0400000004002000040020060401600004016018040160486/17/2008 11:17:26 AM180000001800400018008000PR Newswire USPRN-0005-26040664SCHERING PLOUGH CORPSCHERING-PLOUGH CORPORATION 6.00% MANDATORY CONVERTIBLEFRED HASSANSGPSGP PRBNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-25891538newstex/PRN-0005-25891538xml SEATTLE, Jun. ##, #### (PRNewswire delivered by Newstex) -- Last week the U.S. District Court in New Jersey appointed Hagens Berman, along with four other firms, co-counsel in a case against Schering-Plough (NYSE: SGP) and Merck (NYSE:...0400000004002000040020060200000002002000020020040700000007003000070030016/10/2008 3:15:51 PM1800000018014000PR Newswire USPRN-0005-25891538MERCK & CO INCSCHERING PLOUGH CORPSCHERING-PLOUGH CORPORATION 6.00% MANDATORY CONVERTIBLEMRKSGPSGP PRBNewsNewstexhttp://www.alacrastore.com/storecontent/fitch/388942_report_framefitch/388942_report_framepdfFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Abbott LaboratoriesAmgen, Inc.AstraZeneca plcBristol-Myers Squibb CompanyEli Lilly & CompanyGlaxoSmithKline plcJohnson & JohnsonMerck & Company, Inc.Novartis AGPfizer Inc.Roche Deutschland Holding GmbHSanofi-Aventis S.A.Schering-Plough CorporationWyeth800917408036051680361372803614198036159280361630803624348041717980457972804579768045797980457983806562368071041080843884850944736/9/2008 10:11:00 AM0100000001030000010317000103170301040000275Special ReportABTAMGNAZNBMYGSKJNJLLYMRKNOVNPFESANSGPWYE388942_report_frameCredit & Investment ResearchFitchResearchhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-25686559newstex/PRN-0005-25686559xml KENILWORTH, N.J., Jun. #, #### (PRNewswire-FirstCall delivered by Newstex) -- Schering-Plough Corporation (NYSE: SGP) today reported that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA)...07000000070050000400000004002000040020060701400007014018070140126/2/2008 7:17:03 AM1800000018016000190000001900200019002007PR Newswire USPRN-0005-25686559SCHERING PLOUGH CORPSCHERING-PLOUGH CORPORATION 6.00% MANDATORY CONVERTIBLEFRED HASSANThomas P KoestlerSGPSGP PRBNewsNewstexCHINA - Schering-Plough Corp was rumored to be planning to acquire the remaining ##% stake, which it did not already own, in Shanghai Schering-Plough Pharmaceutical Co Ltd, manufactures pharmaceuticals, from its joint venture partners Shanghai Pharmaceutical (Group) Co Ltd (##%) and Shanghai Pharmaceutical Industry Corp (##%).5/28/2008 1:40:58 PM80660581550C806605806605Schering-Plough CorpShanghai Schering-Plough Pharmaceutical Co LtdSchering-Plough CorpSchering-Plough Corphttp://www.alacrastore.com/storecontent/Thomson_M%26A/Schering_Plough_Corp_is_rumored_to_be_looking_to_purchase_remaining_interest_in_Shanghai_Schering_Plough_Pharm-1980931040sdc/19809310401980931040Copyright © 2008, Thomson Financial, All Rights ReservedNew YorkDrugsUnited StatesPharmaceutical preparations2834NJNew JerseyPublicSGP2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations5122:Drugs, drug proprietaries, and druggists' sundries8731:Commercial physical and biological research2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations5122:Drugs, drug proprietaries, and druggists' sundries8731:Commercial physical and biological researchDrugsChinaPharmaceutical preparations2834FFForeignJoint Venture5356001Mnfr,dvlp,whl pharmMnfr,dvlp,whl pharmNot ApplicableStock1012577001May 28 20080.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000US31 Mar 080.00000-1747.000000.0000014372.0000030120.00000U.S. Dollar0.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.00000Schering-Plough Corp, locatedin Kenilworth, New Jersey,manufactures, develops andsells pharmaceuticals for thetreatment of cardiovasculardiseases, central nervoussystem disorders, immunologyand infectious disease,oncology, respiratory diseasesand women's health. Itslargest-selling productsinclude Vytorin, Zetia,Remicade and Nasonex.Schering-Plough Corp, located in Kenilworth, New Jersey,manufactures, develops and sells pharmaceuticals for thetreatment of cardiovascular diseases, central nervous systemdisorders, immunology and infectious disease, oncology,respiratory diseases and women's health. Its largest-sellingproducts include Vytorin, Zetia, Remicade and Nasonex.Schering-Plough Corp, located in Kenilworth, New Jersey, manufactures, develops and sells pharmaceuticals for the treatment of cardiovascular diseases, central nervous system disorders, immunology and infectious disease, oncology, respiratory diseases and women's health. Its largest-selling products include Vytorin, Zetia, Remicade and Nasonex.1.000002.000003.000004.00000Shanghai Schering-PloughPharmaceutical Co Ltd is apharmaceutical manufacturingfirm, headquartered in China.Shanghai Schering-Plough Pharmaceutical Co Ltd is apharmaceutical manufacturing firm, headquartered in China.Shanghai Schering-Plough Pharmaceutical Co Ltd is a pharmaceutical manufacturing firm, headquartered in China.0.000000.000000.000000.00000Y26 May 08Mon, 26 May 2008 00:00:00 ESTDate Announced: 05/26/2008Date Effective:Acq. Rem. Int.Not Appl.0.000000.000000.000000.000000.000000.00000Price/Share0.0000000.000000.0000000.000000.000000.000000.000000.000000.0000000.00000N0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.0000055.0000045.000000.000000.000000.000000.000000.000000.000000.000000.0000030401.494000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.00000CHINA - Schering-Plough Corpwas rumored to be planning toacquire the remaining 45%stake, which it did notalready own, in ShanghaiSchering-Plough PharmaceuticalCo Ltd, manufacturespharmaceuticals, from itsjoint venture partnersShanghai Pharmaceutical(Group) Co Ltd (30%) andShanghai PharmaceuticalIndustry Corp (15%).CHINA - Schering-Plough Corp was rumored to be planning to acquire the remaining 45% stake, which it did not already own, in Shanghai Schering-Plough Pharmaceutical Co Ltd, manufactures pharmaceuticals, from its joint venture partners Shanghai Pharmaceutical (Group) Co Ltd (30%) and Shanghai Pharmaceutical Industry Corp (15%).CHINA - Schering-Plough Corp was rumored to be planning to acquire the remaining 45%stake, which it did not already own, in Shanghai Schering-Plough Pharmaceutical Co Ltd,manufactures pharmaceuticals, from its joint venture partners Shanghai Pharmaceutical(Group) Co Ltd (30%) and Shanghai Pharmaceutical Industry Corp (15%).CHINA - Schering-Plough Corp was rumored to be planning to acquire the remaining 45% stake, which it did not already own, in Shanghai Schering-Plough Pharmaceutical Co Ltd, manufacturespharmaceuticals, from its joint venture partners Shanghai Pharmaceutical (Group) Co Ltd (30%) and Shanghai Pharmaceutical Industry Corp (15%).CHINA - Schering-Plough Corp was rumored to be planning to acquire the remaining 45% stake, which it did not already own, in ShanghaiSchering-Plough Pharmaceutical Co Ltd, manufactures pharmaceuticals, from its joint venture partners Shanghai Pharmaceutical (Group) CoLtd (30%) and Shanghai Pharmaceutical Industry Corp (15%).Rumor11033.00000-1747.0000014372.0000030120.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Rumor-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000002833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances5356001New YorkUnited States2834New JerseyPublicSGP2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations5122:Drugs, drug proprietaries, and druggists' sundries8731:Commercial physical and biological research5356001New YorkUnited States2834New JerseyPublicSGP0.000000.000000.000000.00000Deal InformationThomson Financial Mergers & Acquisitionshttp://www.alacrastore.com/storecontent/newstex/PRN-0005-25558454newstex/PRN-0005-25558454xml KENILWORTH, N.J., May ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Schering-Plough Corporation (NYSE: SGP) today announced that Janet M. Barth has been appointed vice president, investor relations, effective immediately.In...0400000004016000090000000901500004002000040020065/27/2008 1:17:06 PM1800000018007000PR Newswire USPRN-0005-25558454SCHERING PLOUGH CORPSCHERING-PLOUGH CORPORATION 6.00% MANDATORY CONVERTIBLESGPSGP PRBNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-25546839newstex/BW-0001-25546839xml May ##, #### (Business Wire) -- Santarus, Inc. (NASDAQ:SNTS), a specialty pharmaceutical company, today announced that it has achieved a $#.# million regulatory milestone under its over-the-counter (OTC) license agreement with Schering-Plough...040000000400200004002006040100000401000107000000070140000701401207003000070030015/27/2008 4:16:57 AM1800000018020000180220001900000019001000Business WireBW-0001-25546839SANTARUS INCSCHERING PLOUGH CORPSCHERING-PLOUGH CORPORATION 6.00% MANDATORY CONVERTIBLESGPSGP PRBSNTSNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-25535298newstex/PRN-0005-25535298xml May ##, #### (PR Newswire delivered by Newstex) -- SHANGHAI, China, May ## /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with...04000000040020000400200613000000130020001300200513010000130100050700000007014000070140125/26/2008 10:18:49 AM18000000180070001900000019002000190020041900201319002009PR Newswire USPRN-0005-25535298SCHERING PLOUGH CORPSCHERING-PLOUGH CORPORATION 6.00% MANDATORY CONVERTIBLESGPSGP PRBNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/SINO-0001-25491404newstex/SINO-0001-25491404xml SHANGHAI, May ##, #### (SinoCast delivered by Newstex) -- Shanghai Pharmaceutical (Group) Co., Ltd. and Shanghai Pharmaceutical Industry Corp. Ltd. jointly put a ## percent stake in Shanghai Schering-Plough (NYSE:SGP PRB) (NYSE:SGP)...04000000040180000400200004002006040160000401601307000000070140000701401207003000070030011300000013010000130100055/23/2008 6:14:57 AM1800000018015000180220001900000019002000190020041900200919002013SinoCast's China Business Headline NewsSINO-0001-25491404SCHERING PLOUGH CORPSCHERING-PLOUGH CORPORATION 6.00% MANDATORY CONVERTIBLESGPSGP PRBNewsNewstex